MEPs accuse the European Commission of caving in to US pharmaceutical interests after a trade deal with Trump.
Emese Grancsa
International
Credit: Jacquelyn Martin / AP / Profimedia
Always see our news on Google
Ursula von der Leyen has been criticized by cross-party MEPs over the trade deal with Donald Trump, which excludes pharmaceuticals from tariffs but allows a 15% cap. Many voices in the European People's Party (EPP) and other political groups believe the deal favors the US and weakens the European Union's position. Additional critics are calling for transparency and publication of the details of the deal, pointing out that while economically it is an improvement, it is a political defeat for the EU.
Sources
Eurodeputaţii o acuză pe Ursula von der Leyen că și-a depășit mandatul și a cedat în faţa intereselor americane
Eurodeputații critică acordul negociat de către Ursula von der Leyen cu Donald Trump: „Ambele părţi trebuie să câştige ceva”
'O zi sumbră pentru Europa'. Franța critică acordul comercial dintre UE și SUA
UE: „Nu am luat încă nicio decizie cu privire la web tax”
Latest News
21:22
A fragment of a drone was found near the southern dam of the Midia Port and recovered by military divers. The Ministry of National Defense confirmed that it does not present explosive charges.
21:02
The Kremlin dismissed speculation about a meeting between President Vladimir Putin and rapper Kanye West
20:48
The Constitutional Court of Romania has published the reasoning for the constitutionality decision of the "Fritz" amendment.
20:36
Mircea Abrudean, the president of the Senate, announces an extraordinary session in Parliament between August 24 and 26, dedicated to the reforms in the PNRR.
20:20
The union of employees working with European funds contests the Salary Law and accuses Minister Pîslaru: "His own minister hits the employees whose results he boasts about!"
See more news
NEWS ON THE SAME TOPICS
Personalized news feed, AI-powered search, and notifications in a more interactive experience.
